Rone Peterson Cerqueira Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rone Peterson Cerqueira Oliveira has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Maria Fernanda Rios Grassi
Escola Bahiana de Medicina e Saúde Pública
4 shared publications - Antonio Alceu dos Santos2 shared publications
- Carlos Alberto Maganha
Faculdade de Ciências Médicas de São José dos Campos São José dos CamposSP Brazil Faculdade de Ciências Médicas de São José dos Campos, São José dos Campos, SP, Brazil
2 shared publications - Carolina Carvalho Mocarzel2 shared publications
- Isabel Cristina Céspedes
Universidade Federal de São Paulo
2 shared publications Licia CostaPinto
Escola Bahiana de Medicina e Saúde Pública, Brotas, Salvador, Bahia, Brazil
2 shared publications
Latest Publications
- 1 April 2026
- Published by Federação das Associações de Ginecologia e Obstetrícia in Femina
- Vol. 54 (4) , 296-305
Anemia ferropriva na gestação: prevenção, diagnóstico e tratamento Número 5 – 2026
- 1 April 2026
- Published by Federação das Associações de Ginecologia e Obstetrícia in Femina
- Vol. 54 (4) , 296-305
Anemia ferropriva na gestação: prevenção, diagnóstico e tratamento Número 5 – 2026
- 7 April 2012
- Published by Springer Nature in Rheumatology International
- Vol. 33 (3) , 631-636
Prevalence of Chlamydia trachomatis endocervical infection in systemic lupus erythematosus patients and evaluation of the risk for HPV-induced lesions
Chlamydia trachomatis (CT) is the most common bacterial cause of sexually transmitted disease. It has been associated with arthritis and it is a risk factor for human papillomavirus (HPV)-induced lesions. There are few studies on the frequency of CT infection among systemic lupus erythematosus (SLE) patients. The aim of this study was to determine the prevalence of endocervical CT infection among SLE patients and evaluate whether or not CT infection is a risk factor for HPV-induced lesions. A cross-sectional study included a group of patients who fulfilled the American College Rheumatology criteria for a definite diagnosis of SLE and a control group of non-SLE female individuals from Bahia, Brazil. Polymerase chain reaction was used on endocervical swab specimens to test for CT; a gynecological examination including a cervical cytology and biopsy was done for the identification of HPV lesions. A total of 105 SLE patients were studied, and the control group was composed of 104 age-matched apparently normal women. The prevalence of CT endocervical infection was 3.0 % [confidence interval (CI) 95 % = 0.6–8.0 %] in the SLE group and 5.0 % (95 % CI = 2.0–11.0 %) in the control group; the prevalence ratio was 0.60 (95 % CI = 0.1–2.5). The prevalence of vulvar condyloma was higher among SLE patients (11.0 vs. 1.0 %, p < 0.001), as were the prevalences of low-grade lesion (12.0 vs. 1.0 %, p < 0.001) and cervical intraepithelial neoplasia 1 (9.0 vs. 1.0 %, p = 0.02). There was no association between the presence of HPV lesions and CT infections. However, the small number of patients with CT prevents a definite conclusion from being drawn. The prevalence of endocervical CT infection in women with SLE is low and similar to that of the normal population. This suggests that this infection has no role in the pathogenesis of SLE or the development of HPV-induced lesions.
- 7 April 2012
- Published by Springer Nature in Rheumatology International
- Vol. 33 (3) , 631-636
Prevalence of Chlamydia trachomatis endocervical infection in systemic lupus erythematosus patients and evaluation of the risk for HPV-induced lesions
Chlamydia trachomatis (CT) is the most common bacterial cause of sexually transmitted disease. It has been associated with arthritis and it is a risk factor for human papillomavirus (HPV)-induced lesions. There are few studies on the frequency of CT infection among systemic lupus erythematosus (SLE) patients. The aim of this study was to determine the prevalence of endocervical CT infection among SLE patients and evaluate whether or not CT infection is a risk factor for HPV-induced lesions. A cross-sectional study included a group of patients who fulfilled the American College Rheumatology criteria for a definite diagnosis of SLE and a control group of non-SLE female individuals from Bahia, Brazil. Polymerase chain reaction was used on endocervical swab specimens to test for CT; a gynecological examination including a cervical cytology and biopsy was done for the identification of HPV lesions. A total of 105 SLE patients were studied, and the control group was composed of 104 age-matched apparently normal women. The prevalence of CT endocervical infection was 3.0 % [confidence interval (CI) 95 % = 0.6–8.0 %] in the SLE group and 5.0 % (95 % CI = 2.0–11.0 %) in the control group; the prevalence ratio was 0.60 (95 % CI = 0.1–2.5). The prevalence of vulvar condyloma was higher among SLE patients (11.0 vs. 1.0 %, p < 0.001), as were the prevalences of low-grade lesion (12.0 vs. 1.0 %, p < 0.001) and cervical intraepithelial neoplasia 1 (9.0 vs. 1.0 %, p = 0.02). There was no association between the presence of HPV lesions and CT infections. However, the small number of patients with CT prevents a definite conclusion from being drawn. The prevalence of endocervical CT infection in women with SLE is low and similar to that of the normal population. This suggests that this infection has no role in the pathogenesis of SLE or the development of HPV-induced lesions.
- 27 March 2012
- Published by Springer Nature in Rheumatology International
- Vol. 33 (2) , 335-340
Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus
Genital infection by human papillomavirus (HPV) tends to occur more frequently in patients with conditions associated with immune suppression. Systemic lupus erythematosus (SLE) is an immunological disorder characterized by generalized inflammation and a number of clinical manifestations and circulating autoantibodies. The aim of the present study was to determine the prevalence of genital HPV infection among female SLE patients. Women diagnosed with SLE based on American College of Rheumatology classification criteria followed at rheumatology outpatient clinic of the Escola Bahiana de Medicina e Saude Publica, Salvador, Brazil, were included in the study. As a comparison group, clinically healthy women who were attending the gynecology outpatient clinic for routine examination at the same institution were recruited. Testing for cervical HPV infection was performed using the nested polymerase chain reaction technique. Eighty-eight female SLE patients (mean age, 41.4 ± 11.6 years) and seventy healthy female subjects (control group) were studied. The prevalence of HPV infection was 80.7 % (71/88) in the SLE group and 35.7 % (25/70) in the control group (p < 0.0001). After adjustment of the variables (early sexual activity, number of partners and obstetric history), the odds ratio (OR) for genital HPV infection in women with SLE was 7.2 (95 % CI, 2.9 to 17.8; p = 0.0001). The use of immunosuppressive drugs was not associated with a higher prevalence of HPV infection. This study demonstrated that SLE patients have a higher prevalence of genital HPV infection, even when exposed to less potential risk factors for the virus.
- 27 March 2012
- Published by Springer Nature in Rheumatology International
- Vol. 33 (2) , 335-340
Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus
Genital infection by human papillomavirus (HPV) tends to occur more frequently in patients with conditions associated with immune suppression. Systemic lupus erythematosus (SLE) is an immunological disorder characterized by generalized inflammation and a number of clinical manifestations and circulating autoantibodies. The aim of the present study was to determine the prevalence of genital HPV infection among female SLE patients. Women diagnosed with SLE based on American College of Rheumatology classification criteria followed at rheumatology outpatient clinic of the Escola Bahiana de Medicina e Saude Publica, Salvador, Brazil, were included in the study. As a comparison group, clinically healthy women who were attending the gynecology outpatient clinic for routine examination at the same institution were recruited. Testing for cervical HPV infection was performed using the nested polymerase chain reaction technique. Eighty-eight female SLE patients (mean age, 41.4 ± 11.6 years) and seventy healthy female subjects (control group) were studied. The prevalence of HPV infection was 80.7 % (71/88) in the SLE group and 35.7 % (25/70) in the control group (p < 0.0001). After adjustment of the variables (early sexual activity, number of partners and obstetric history), the odds ratio (OR) for genital HPV infection in women with SLE was 7.2 (95 % CI, 2.9 to 17.8; p = 0.0001). The use of immunosuppressive drugs was not associated with a higher prevalence of HPV infection. This study demonstrated that SLE patients have a higher prevalence of genital HPV infection, even when exposed to less potential risk factors for the virus.
- Open Access
- 1 May 2011
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 15 (3) , 239-244
Candida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil
- 1 May 2011
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 15 (3) , 239-244
Open AccessCandida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil
- Open Access
- 1 March 2008
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 30 (3) , 121-126
Vulvovaginites em mulheres infectadas pelo vírus da imunodeficiência humana
OBJETIVO: comparar a freqüência de vulvovaginites em mulheres infectadas pelo vírus da imunodeficiência humana (HIV) com mulheres não infectadas. MÉTODOS: estudo de corte transversal com 64 mulheres infectadas pelo HIV e 76 não infectadas. Foram calculadas as freqüências de vaginose bacteriana, candidíase e tricomoníase, que foram diagnosticadas por critérios de Amsel, cultura e exame a fresco, respectivamente. Para análise dos dados, utilizaram-se o teste do c2, teste exato de Fisher e regressão múltipla para verificar a independência das associações. RESULTADOS: a infecção vaginal foi mais prevalente em pacientes infectadas pelo HIV quando comparadas ao Grupo Controle (59,4 versus 28,9%, p<0,001; Odds Ratio=2,7, IC95%=1,33-5,83, p=0,007). Vaginose bacteriana ocorreu em 26,6% das mulheres HIV positivas; candidíase vaginal, em 29,7% e tricomoníase, em 12,5%. Todas foram significativamente mais freqüentes no grupo de mulheres infectadas pelo HIV (p=0,04, 0,02 e 0,04, respectivamente). CONCLUSÕES: vulvovaginites são mais freqüentes em mulheres infectadas pelo HIV.
- 1 March 2008
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Ginecologia e Obstetrícia
- Vol. 30 (3) , 121-126
Open AccessVulvovaginites em mulheres infectadas pelo vírus da imunodeficiência humana
OBJETIVO: comparar a freqüência de vulvovaginites em mulheres infectadas pelo vírus da imunodeficiência humana (HIV) com mulheres não infectadas. MÉTODOS: estudo de corte transversal com 64 mulheres infectadas pelo HIV e 76 não infectadas. Foram calculadas as freqüências de vaginose bacteriana, candidíase e tricomoníase, que foram diagnosticadas por critérios de Amsel, cultura e exame a fresco, respectivamente. Para análise dos dados, utilizaram-se o teste do c2, teste exato de Fisher e regressão múltipla para verificar a independência das associações. RESULTADOS: a infecção vaginal foi mais prevalente em pacientes infectadas pelo HIV quando comparadas ao Grupo Controle (59,4 versus 28,9%, p<0,001; Odds Ratio=2,7, IC95%=1,33-5,83, p=0,007). Vaginose bacteriana ocorreu em 26,6% das mulheres HIV positivas; candidíase vaginal, em 29,7% e tricomoníase, em 12,5%. Todas foram significativamente mais freqüentes no grupo de mulheres infectadas pelo HIV (p=0,04, 0,02 e 0,04, respectivamente). CONCLUSÕES: vulvovaginites são mais freqüentes em mulheres infectadas pelo HIV.